PFM Health Sciences, LP - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 213 filers reported holding NEVRO CORP in Q2 2021. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
PFM Health Sciences, LP ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2022$26,262,000
-9.1%
563,560
-14.5%
0.95%
-13.9%
Q2 2022$28,902,000
-38.5%
659,410
+1.5%
1.10%
-37.2%
Q1 2022$46,979,000
+19.4%
649,513
+33.9%
1.76%
+31.2%
Q4 2021$39,330,000
-14.0%
485,135
+23.5%
1.34%
-0.4%
Q3 2021$45,712,000
-34.1%
392,786
-6.2%
1.34%
-38.2%
Q2 2021$69,407,000
+11.8%
418,645
-5.9%
2.18%
+14.8%
Q1 2021$62,060,000
+14.9%
444,877
+42.6%
1.90%
-0.3%
Q4 2020$53,997,000
+21.8%
311,940
-2.0%
1.90%
-7.3%
Q3 2020$44,330,000
+256.2%
318,232
+205.5%
2.05%
+217.3%
Q2 2020$12,446,000
-81.7%
104,180
-81.9%
0.65%
-80.0%
Q4 2019$67,840,000
+99.1%
577,163
+45.6%
3.23%
+221.2%
Q3 2019$34,067,000
-36.8%
396,270
-52.3%
1.01%
-1.7%
Q2 2019$53,863,000
+19.5%
830,834
+15.2%
1.02%
+2.7%
Q1 2019$45,084,000
+108.5%
721,229
+29.7%
1.00%
+73.2%
Q4 2018$21,627,000
+97.5%
556,095
+376.0%
0.58%
+109.9%
Q1 2017$10,948,000116,8360.27%
Other shareholders
NEVRO CORP shareholders Q2 2021
NameSharesValueWeighting ↓
Tiger Eye Capital LLC 239,122$41,392,0008.25%
Integral Health Asset Management, LLC 88,000$15,233,0004.53%
Iron Triangle Partners LP 168,761$29,213,0003.79%
Eos Focused Equity Management, L.P. 14,002$2,424,0002.37%
PFM Health Sciences, LP 311,940$53,997,0001.90%
Perceptive Advisors 977,565$169,217,0001.82%
Rock Springs Capital Management LP 395,000$68,375,0001.45%
Lisanti Capital Growth, LLC 54,302$9,400,0001.30%
HealthCor Management, L.P. 156,046$27,012,0001.04%
FRED ALGER MANAGEMENT, LLC 2,136,612$369,848,0000.96%
View complete list of NEVRO CORP shareholders